-
Hikma Announces Expanded Licensing Agreement with Takeda
pharmaceutical-technology
August 21, 2017
Hikma Pharmaceuticals has reached an agreement with Takeda Pharmaceutical to expand its licensing and distribution agreement adding new products to its portfolio in the Middle East and North Africa (MENA).
-
Hikma and Takeda sign new licensing agreement to expand product portfolio in MENA
pharmaceutical-technology
August 21, 2017
Hikma Pharmaceuticals has reached an agreement with Takeda Pharmaceutical Company to expand their licensing and distribution agreement to add new products to its existing portfolio in the Middle East and North Africa (MENA).
-
Takeda R&D reboot continues with Stanford drug discovery deal
fiercebiotech
August 17, 2017
Four to eight projects will be run by the partners at any given time.
-
Takeda Announces Alliance with Stanford University
americanpharmaceuticalreview
August 16, 2017
Takeda announced a collaboration with Stanford University to form the Stanford Alliance for Innovative Medicines (Stanford AIM), which will help transform novel Stanford research into next-generation treatments for diseases.
-
Takeda strikes partnership to develop single-drug cancer combo immunotherapies
pharmafile
August 15, 2017
Japanese pharma giant Takeda has announced that it is to partner up with US-based Shattuck Labs in a collaboration to develop checkpoint fusion proteins which can be refined and utilised as highly differentiated, advanced immunotherapies for cancer.
-
Takeda and Shattuck Labs partner to develop immunotherapies for cancer treatments
pharmaceutical-technology
August 15, 2017
Takeda Pharmaceutical has entered a research collaboration with Shattuck Labs to study and develop checkpoint fusion proteins that have the potential to be used as highly differentiated, advanced immunotherapies for cancer.
-
Takeda Allies with Austin for 'double whammy' cancer immunotherapies
fiercebiotech
August 14, 2017
The deal adds to a long list of alliances between Takeda and small biotechs.
-
Takeda, Shattuck Labs Announce Research Collaboration
americanpharmaceuticalreview
August 11, 2017
Takeda Pharmaceutical Company and Shattuck Labs announced they have entered into a research collaboration to explore and develop checkpoint fusion proteins,Takeda will hold options for exclusive global development and commercialization rights for up to fo
-
Takeda reveals collaboration aimed at bolstering oncology pipeline
pharmafile
August 09, 2017
It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move to prepare for this after signing a licensing collaboration with Molecular Templates.
-
Spoiler alert: IBD superheroes prevail as Takeda wraps its Marvel Comics project
fiercepharma
August 08, 2017
Takeda's IBD superheroes are back for the last chapters of its Marvel Comics custom-created graphic novel